Rosenblatt Maintains Buy on Imax, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel maintains a Buy rating on Imax (NYSE:IMAX) with a $28 price target.
October 04, 2024 | 3:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel reaffirms a Buy rating on Imax, maintaining a $28 price target, indicating confidence in the company's future performance.
The reaffirmation of a Buy rating and a $28 price target by Rosenblatt suggests a positive outlook for Imax, likely boosting investor confidence and potentially leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100